Navigation Links
Boehringer Ingelheim's investigational volasertib receives FDA Breakthrough Therapy designation
Date:9/17/2013

to advance Plk inhibitors into clinical development.

Volasertib is designed to inhibit the activity of Plk1, an enzyme in the Plk family that regulates cell division (mitosis).  This inhibition is intended to result in prolonged cell cycle arrest, ultimately leading to cell death (apoptosis).10

Volasertib* is not approved by the FDA; its safety and efficacy have not been established.

About Boehringer Ingelheim in Oncology
Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research program to discover and develop innovative cancer treatments.  Working in close collaboration with the international scientific community and a number of the world's leading cancer centers, Boehringer Ingelheim's commitment to oncology is underpinned by using advances in science to develop a range of targeted therapies for various solid tumors and hematological cancers. The current focus of late-stage research includes compounds in three areas: signal transduction inhibition, angiogenesis inhibition and cell-cycle kinase inhibition. The company is also evaluating a robust and growing pipeline of early-stage oncology compounds in areas including growth/survival signaling, immunotherapy and epigenetics.

For information about participating in a Boehringer Ingelheim clinical trial, please visit www.bicancertrials.com or call 1.866.725.7110. Healthcare providers interested in learning more about Boehringer Ingelheim clinical trials in oncology can visit www.inoncologyus.com for additional information. 

About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehri
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
2. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
6. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
7. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
8. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
10. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
11. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... of Americans believe the abuse of strong prescription pain medications ... issue in the United States , according ... Partners, a Cincinnati based research firm. ... prescription medication abuse problem and the need for medical innovation ... our country," Rex Repass , CEO of the survey ...
(Date:8/21/2014)... InfinityQS International, Inc., the global authority ... today announces Infusion Chicago, its 9 th ... Oct. 9-10, 2014, at the Chicago Marriott Downtown ... necessity for implementing a quality system that optimizes ... gain insight into production processes. Complimentary registrations are ...
(Date:8/21/2014)... 2014 Professional Compounding Centers of America ... awarding the three best scientific presentations at the ... . The Formulating Better Medicines for Children ... Athens, Greece , includes dozens of ... from which three winners will be selected by ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Diabetics Twice as Likely to Have Hearing Loss; New York HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2Diabetics Twice as Likely to Have Hearing Loss; New York HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3Diabetics Twice as Likely to Have Hearing Loss; New York HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4Diabetics Twice as Likely to Have Hearing Loss; New York HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 6Diabetics Twice as Likely to Have Hearing Loss; North Carolina HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 7
(Date:8/22/2014)... leather seat covers provided by Lseat.comare meticulously in ... product needs. Recently, the company has unveiled its latest assortment ... company wants to provide worldwide clients with more high quality ... for a long time. According to the company’s sales manager, ... Among all the new products, Chevrolet Camaro leather seat ...
(Date:8/22/2014)... PA (PRWEB) August 22, 2014 AcousticSheep LLC ... in Erie, PA yet – the first Color Run – otherwise ... place on August 9, 2014 and over 10,900 participants from Erie, ... or walked in it.participated in one of the largest running events ... – otherwise known as the “Happiest 5K on the Planet.” The ...
(Date:8/22/2014)... August 22, 2014 For the fourth ... reward and recognition industry, has received a prestigious level ... growth rate of 134%, TharpeRobbins remains on the exclusive ... America. TharpeRobbins was previously on the list in 2010, ... be included in this distinguished list for a fourth ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 Minorities in ... groups when it comes to mental health and recovery from ... trying to bridge the gap between local minorities and the ... is pitching in by making the connection between mental and ... a fundraising event at their fitness boot camp, located at ...
(Date:8/22/2014)... NE (PRWEB) August 22, 2014 Medical ... once again earned a position on the Inc. 5000 ... staffing company placed in position 1424 on the list, ... of $126.2 million. This marks the seventh time in ... a spot on the Inc. 5000, including one year ...
Breaking Medicine News(10 mins):Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 3Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3Health News:Fountain Valley Fit Body Boot Camp Announces Fitness Boot Camp Fundraising Event for Casa de Familia 2Health News:Fountain Valley Fit Body Boot Camp Announces Fitness Boot Camp Fundraising Event for Casa de Familia 3Health News:Medical Solutions Earns Position on the 2014 Inc. 5000 List 2
... July 27 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical ... today announced data suggesting that QPI-1007 prevents progressive retinal ... (IOP) rat model of glaucoma. The experiments performed by ... and Cell Biology, Universite de Montreal, indicate that QPI-1007 ...
... , , DALLAS, July ... (OTC Bulletin Board: ACCP) announced today that its European partner, ... MuGard in Norway. This follows previous commercial launches in the ... is responsible for manufacturing, regulatory approval and commercialization in the 27 countries ...
... July 27 American CareSource Holdings, Inc. (Nasdaq: ... announced the expansion of its ancillary services provider network with ... retail-based health care centers in the United States with about ... Minneapolis-based MinuteClinic is a subsidiary of CVS Caremark Corporation (NYSE: ...
... , , ... Inc. (OTC Bulletin Board: AEMD) today disclosed it has entered ... with the U.S. Army Medical Research Institute of Infectious Diseases ... Hemopurifier(R) is the first-in-class medical device to selectively adsorb viruses ...
... processed, stored in the brain , MONDAY, July 27 (HealthDay ... will probably rev up. , An international team of researchers ... when people recognize a photo or name, even if the ... perfect fashion. , "Different pictures of Marilyn Monroe can evoke ...
... , SOUTH SAN FRANCISCO, Calif., July 27 ... that Helen S. Kim has been appointed to the company,s Board ... Enterprise Associates, which purchased approximately $2.3 million of the company,s securities ... , "We are pleased to have Helen join ...
Cached Medicine News:Health News:Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma 2Health News:Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma 3Health News:Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm 2Health News:Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm 3Health News:Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm 4Health News:American CareSource Holdings Increases ACS Network's Convenience and Quality With MinuteClinic Signing 2Health News:American CareSource Holdings Increases ACS Network's Convenience and Quality With MinuteClinic Signing 3Health News:American CareSource Holdings Increases ACS Network's Convenience and Quality With MinuteClinic Signing 4Health News:Aethlon Medical Announces U.S. Army Agreement 2Health News:Aethlon Medical Announces U.S. Army Agreement 3Health News:Famous Names Get Single Neurons Fired Up 2Health News:Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors 2
Titanium. Straight shafts with curved lower tip. Upper tip fits into positioning hole while lower jaw stabilizes the lens. Flat smooth handle with dull finish. Most popular size or model....
Hydroview insertion forcep with very thin jaws to allow insertion through tunnel or clear cornea incision. Locking. Made in titanium....
... ideal for insertions of the latest designs of ... to prevent migration of the lens from the ... eases fingertip manipulations of the instrument for precise ... provided for ease of loading and release of ...
... fold most flexible intraocular lens for ... instruments. The notched jaws align the ... precise fold. Ideal for lens diameters ... platform on tip is great for ...
Medicine Products: